| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGUCAGCGUUCCUCGGGCCCUCGGCGCCACGAGCUGUCCGGGCACGCAG… | 6821 nt | 0.3592 | |
| UUCUGCUAUAGAGAUGGAACAGUAUAUGGAAAGCUCCCAAGAAAGUGAA… | 2313 nt | 0.3865 | |
| AGUCAGCGUUCCUCGGGCCCUCGGCGCCACGAGCUGUCCGGGCACGCAG… | 6984 nt | 0.3655 | |
| AGUCAGCGUUCCUCGGGCCCUCGGCGCCACGAGCUGUCCGGGCACGCAG… | 2465 nt | 0.4308 | |
| AGUCAGCGUUCCUCGGGCCCUCGGCGCCACGAGCUGUCCGGGCACGCAG… | 2267 nt | 0.4195 | |
| AGUCAGCGUUCCUCGGGCCCUCGGCGCCACGAGCUGUCCGGGCACGCAG… | 6871 nt | 0.3647 |
This gene is a member of the STEAP family and encodes a multi-pass membrane protein that localizes to the Golgi complex, the plasma membrane, and the vesicular tubular structures in the cytosol. A highly similar protein in mouse has both ferrireductase and cupric reductase activity, and stimulates the cellular uptake of both iron and copper in vitro. Increased transcriptional expression of the human gene is associated with prostate cancer progression. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
A study in human HT-29 colorectal adenocarcinoma cells demonstrated that exposure to arsenic trioxide (As2O3) significantly suppressed the STEAP2 gene by -4.55-fold according to microarray analysis, with a decreasing tendency confirmed by qRT-PCR [Kazuta et al. DOI:10.1016/J.Legalmed.2026.102774].